Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Johnson’s Draft Gainsharing Bill Provides Some Safeguards For Devices

This article was originally published in The Gray Sheet

Executive Summary

Hospitals would need to make "therapeutic equivalent medical products" that are excluded from gainsharing programs available for physicians to use, under a draft bill being circulated by Rep. Nancy Johnson (R-Conn.)
Advertisement

Related Content

Ortho Firms And Docs Claim That Gainsharing Reality Is Not Meeting Its Hype
Ortho Firms And Docs Claim That Gainsharing Reality Is Not Meeting Its Hype
AdvaMed: Gainsharing Demo Programs Proposed In Draft Bill Are Too Large
AdvaMed: Gainsharing Demo Programs Proposed In Draft Bill Are Too Large
Gainsharing Should Be Limited To Case-By-Case Approvals – OIG’s Morris
Gainsharing Should Be Limited To Case-By-Case Approvals – OIG’s Morris
Gainsharing Will Be Scrutinized At An Upcoming Ways & Means Hearing
HCA Initiates Physician Enrollment For Its Orthopedics Gainsharing Program
Advertisement
UsernamePublicRestriction

Register

MT022921

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel